The life expectancy  of non-Hispanic Black men who have sex with men  and who acquire HIV is 6.3 years shorter than their White counterparts when receiving status quo HIV care in the United States, according to simulation modeling findings presented at IDWeek.

A bivalent mRNA booster vaccine targeting the Omicron BA.1 variant of COVID-19 produces a significantly higher antibody response compared to the original vaccine with no new safety concerns, according to research presented at IDWeek.

COVID-19 is associated with reported long-term effects on the physical fitness of U.S. military members.

The Infectious Diseases Society of America is honoring 12 of its members who are leaders in the field at IDWeek 2022. IDSA recognizes the following for excellence in the field of infectious diseases.

IDSA urges everyone who is eligible to get boosted now as COVID-19 cases increase in Europe and other parts of the world — a sign that a surge could happen in the United States.

IDSA and HIVMA are pleased that global efforts to end the HIV, tuberculosis and malaria epidemics received much needed investment at the seventh replenishment of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

IDSA and HIVMA strongly oppose government interference in the patient-health care provider relationship and religious refusal laws and regulations that allow health care professionals, employers, systems or insurers to deny access to services based on their own personal religious beliefs.

IDSA supports decisions by the Food and Drug Administration and the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices to authorize and recommend boosters meant to curb cases of more highly infectious strains of COVID-19.